PDGFRA-associated chronic eosinophilic leukemia
Last updated 14 Dec 2022
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
PDGFRA-associated chronic eosinophilic leukemia is a form of blood cell cancer characterised by an elevated number of cells called eosinophils in the blood. These cells help fight infections by certain parasites and are involved in the inflammation associated with allergic reactions. However, these circumstances do not account for the increased number of eosinophils in PDGFRA-associated chronic eosinophilic leukemia.
Video picks for Genetic conditionsVideo library
Description
PDGFRA-associated chronic eosinophilic leukemia is a form of blood cell cancer characterised by an elevated number of cells called eosinophils in the blood. These cells help fight infections by certain parasites and are involved in the inflammation associated with allergic reactions. However, these circumstances do not account for the increased number of eosinophils in PDGFRA-associated chronic eosinophilic leukemia.
Another characteristic feature of PDGFRA-associated chronic eosinophilic leukemia is organ damage caused by the excess eosinophils. Eosinophils release substances to aid in the immune response, but the release of excessive amounts of these substances causes damage to one or more organs, most commonly the heart, skin, lungs, or nervous system. Eosinophil-associated organ damage can lead to a heart condition known as eosinophilic endomyocardial disease, skin rashes, coughing, difficulty breathing, swelling (edema) in the lower limbs, confusion, changes in behaviour, or impaired movement or sensations. People with PDGFRA-associated chronic eosinophilic leukemia can also have an enlarged spleen (splenomegaly) and elevated levels of certain chemicals called vitamin B12 and tryptase in the blood.
Some people with PDGFRA-associated chronic eosinophilic leukemia have an increased number of other types of white blood cells, such as neutrophils or mast cells. Occasionally, people with PDGFRA-associated chronic eosinophilic leukemia develop other blood cell cancers, such as acute myeloid leukemia or B-cell or T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
PDGFRA-associated chronic eosinophilic leukemia is often grouped with a related condition called hypereosinophilic syndrome. These two conditions have very similar signs and symptoms; however, the cause of hypereosinophilic syndrome is unknown.
Inheritance patterns
The source lists the following possible inheritance patterns: Not inherited. More than one pattern can apply in different cases.
Related genes
Other names
Chronic eosinophilic leukemia with FIP1L1-PDGFRA
Myeloid and lymphoid neoplasms associated with PDGFRA rearrangement
Myeloid and lymphoid neoplasms with PDGFRA rearrangement
Myeloid/lymphoid neoplasms with PDGFRA rearrangement
PDGFRA-associated myeloproliferative neoplasm
Patient picks for Genetic conditions

Cancer
Chronic myeloid leukaemia
Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia.
by Dr Laurence Knott

Senior health
Navigating Christmas with a chronic illness
While Christmas really can be 'the most wonderful time of the year', the festivities aren't joyful for everyone. If you live with a chronic illness, it's understandable if you find Christmas stressful or anxiety-inducing. However, it is possible to find enjoyment in the festive season alongside managing your conditions.
by Emily Jane Bashforth

Cancer
Chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia (CLL) is a condition where you have many abnormal B lymphocyte white blood cells.
by Dr Laurence Knott

Digestive health
Eosinophilic oesophagitis
The oesophagus is the gullet, or food pipe, that connects the mouth to the stomach. Inflammation of the oesophagus is known as oesophagitis. Commonly, the inflammation is caused by acid leaking up from the stomach (a condition known as acid reflux). In some people, however, it can be caused by a condition known as eosinophilic oesophagitis. In eosinophilic oesophagitis, particular types of white blood cells (called eosinophils) gather in large numbers in the lining of the oesophagus, causing inflammation. It occurs in children and in adults. The condition can be controlled by making changes to your diet and/or taking steroids. Occasionally, an operation to stretch the oesophagus through a telescope (endoscope) may be needed.
by Dr Rachel Hudson, MRCGP

Chest and lungs
What is eosinophilic asthma and what makes it different?
For many people living with asthma, identifying triggers and getting the right treatment can make managing their condition easier on a day-to-day basis. But for people with eosinophilic asthma, symptoms and onset can be more unusual and harder to treat - and that in turn may make diagnosis and management more difficult.
by Dr Sarah Jarvis

Ear, nose and throat
Chronic sinusitis
Chronic sinusitis is inflammation of the sinuses that lasts a long time, usually defined as 12 weeks or more. It is less common than acute sinusitis, but appears to be getting more common in all age groups. There are lots of treatments. Surgery to improve the drainage of the sinus is an option if other treatments fail, and usually works well.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Chronic myeloid leukaemia
Chronic myeloid leukaemia (CML) is sometimes called chronic myelogenous leukaemia, chronic granulocytic leukaemia, or chronic myelocytic leukaemia. What is chronic myeloid leukaemia. CML develo... The abnormal stem cell multiplies and the cells that are made from the abnormal stem cells mature and develop into near-normal white cells - mainly.

Patient information leaflet
Full blood count and blood film
Too many white blood cells - this i... Depending on which type of white cell is increased it is called neutrophilia, lymphocytosis, eosinophilia, monocytosis or basophilia. There are various causes - for example: Various infections can cause an increase of white blood cells. Certain allergies can cause an eosinophilia. Leukaemia Leukaemia is a.

Patient information leaflet
Childhood leukaemias
There are different types of white cells, which are called neutrophils (polymorphs), lymphocytes, eosinophils, monocytes and basophils. Chronic myeloid leukaemia (CML) can occur in children but is much less common and chronic lymphocytic leukaemia (CLL) is very rare in childhood. ...ic myeloid leukaemia (CML) CML developsThe cells that are made.

Patient information leaflet
Immunisation for flu
What is the flu jab for. Influenza (flu) Flu is a common viral infection that tends to be most common in the winter. Flu can cause much more severe symptoms than the common cold Common cold. Some people can become seriously ill with flu, needing hospital treatment, and it can be life-threatening. Certain groups of people, such as older adults and.

Patient information leaflet
Polycythaemia rubra vera
You may also have an abnormally high number of platelets and white blood cells. What is normal blood made up of. White cells (leukocytes). There are different types of white cells, which are called neutrophils (polymorphs), lymphocytes, eosinophils, monocytes and basophils. They are part of the immune system. This causes your blood to flow more.

Patient information leaflet
Dysphagia
This leaflet discusses the main causes of dysphagia. Oesophagitis due to acid reflux is common, but a... Eosinophilic oesophagitis This is another type of inflammation of the oesophagus with a different cause and different treatment. It is an increasingly common cause of difficulty swallowing. See the separate leaflet called Eosinophilic.
Further reading and references
- PDGFRA-associated chronic eosinophilic leukemia; MedlinePlus, National Library of Medicine.
- Buitenhuis M, Verhagen LP, Cools J, Coffer PJ. Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation. Cancer Res. 2007 Apr 15;67(8):3759-66. doi: 10.1158/0008-5472.CAN-06-4183.
- Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003 Mar 27;348(13):1201-14. doi: 10.1056/NEJMoa025217.
- Elling C, Erben P, Walz C, Frickenhaus M, Schemionek M, Stehling M, Serve H, Cross NC, Hochhaus A, Hofmann WK, Berdel WE, Muller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease. Blood. 2011 Mar 10;117(10):2935-43. doi: 10.1182/blood-2010-05-286757. Epub 2011 Jan 11.
- Fukushima K, Matsumura I, Ezoe S, Tokunaga M, Yasumi M, Satoh Y, Shibayama H, Tanaka H, Iwama A, Kanakura Y. FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells. J Biol Chem. 2009 Mar 20;284(12):7719-32. doi: 10.1074/jbc.M807489200. Epub 2009 Jan 14.
- Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C, Popp H, Haferlach T, Erben P, Mix J, Muller MC, Beneke H, Muller L, Del Valle F, Aulitzky WE, Wittkowsky G, Schmitz N, Schulte C, Muller-Hermelink K, Hodges E, Whittaker SJ, Diecker F, Dohner H, Schuld P, Hehlmann R, Hochhaus A, Cross NC, Reiter A. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia. 2007 Jun;21(6):1183-8. doi: 10.1038/sj.leu.2404662. Epub 2007 Mar 22.
- Roufosse FE, Goldman M, Cogan E. Hypereosinophilic syndromes. Orphanet J Rare Dis. 2007 Sep 11;2:37. doi: 10.1186/1750-1172-2-37.
- Vandenberghe P, Wlodarska I, Michaux L, Zachee P, Boogaerts M, Vanstraelen D, Herregods MC, Van Hoof A, Selleslag D, Roufosse F, Maerevoet M, Verhoef G, Cools J, Gilliland DG, Hagemeijer A, Marynen P. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia. 2004 Apr;18(4):734-42. doi: 10.1038/sj.leu.2403313.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

